4,424
Participants
Start Date
May 31, 2012
Primary Completion Date
September 30, 2012
Study Completion Date
September 30, 2012
insulin
Patients will be asked to complete 2 self-assessment questionnaires
Novo Nordisk Investigational Site, Paris La Défense Cedex
Lead Sponsor
Novo Nordisk A/S
INDUSTRY